| Financial Year |
March 31 2023 |
| Monetary Funds |
1,705,473,827.52 |
| Held-for-trading Financial Assets |
70,963,178.80 |
| Notes Receivable |
-- |
| Accounts Receivable |
159,750,344.54 |
| Advances to Suppliers |
13,094,183.36 |
| Other Receivables |
46,547,130.69 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
3,975,000.00 |
| Inventories |
126,820,215.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,300,142.40 |
| Total Current Assets |
2,130,949,022.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
619,625,199.85 |
| Investment Properties |
37,290,310.53 |
| Fixed Assetes |
863,732,401.62 |
| Under-construction Projects |
12,604,100.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
422,987,999.04 |
| R&D expenses |
-- |
| Goodwill |
37,943,975.64 |
| Long-Term Deferred and Prepaid Expenses |
6,708,271.72 |
| Deferred Income Tax Assets |
5,853,621.97 |
| Other Non-Current Assets |
5,862,216.00 |
| Sub-Total of Non-Current Assets |
2,935,341,872.90 |
| Total Assets |
5,066,290,895.30 |
| Short-Term Loans |
89,000,151.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
14,800,000.00 |
| Accounts Payable |
65,599,704.64 |
| Accounts Received In Advance |
8,146,605.74 |
| Employee Compensation Payable |
124,999,646.29 |
| Taxes Payable |
24,622,113.16 |
| Interest Payable |
-- |
| Dividend Payable |
20,701,320.85 |
| Other payables |
228,852,152.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,722,614.73 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
596,845,578.96 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,015,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
202,412,342.64 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
319,631,900.77 |
| Total Liabilities |
916,477,479.73 |
| Paid-In Capital(Or Share Stock) |
551,610,107.00 |
| Capital Surplus |
297,169,588.30 |
| Surplus Reserve |
286,489,689.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,190,811,918.58 |
| Minority Stockholder's Interest |
246,015,219.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,903,798,196.34 |
| Owner's Equity（Stockholder's Equity） |
4,149,813,415.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,066,290,895.30 |
